Nektar Therapeutics (NKTR)
NASDAQ: NKTR · IEX Real-Time Price · USD
1.390
+0.040 (2.96%)
At close: Jul 19, 2024, 4:00 PM
1.400
+0.010 (0.72%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Nektar Therapeutics Market Cap
Nektar Therapeutics has a market cap or net worth of $255.79 million as of July 22, 2024. Its market cap has increased by 147.14% in one year.
Market Cap
255.79M
Enterprise Value
80.63M
1-Year Change
147.14%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since December 1, 1998, Nektar Therapeutics's market cap has decreased from $478.60M to $255.79M, a decrease of -46.55%. That is a compound annual growth rate of -2.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 255.20M | 136.73% |
| Dec 29, 2023 | 107.80M | -74.62% |
| Dec 30, 2022 | 424.80M | -82.96% |
| Dec 31, 2021 | 2.49B | -18.24% |
| Dec 31, 2020 | 3.05B | -19.69% |
| Dec 31, 2019 | 3.80B | -33.26% |
| Dec 31, 2018 | 5.69B | -39.50% |
| Dec 29, 2017 | 9.40B | 401.47% |
| Dec 30, 2016 | 1.88B | -16.61% |
| Dec 31, 2015 | 2.25B | 12.95% |
| Dec 31, 2014 | 1.99B | 51.06% |
| Dec 31, 2013 | 1.32B | 54.43% |
| Dec 31, 2012 | 853.40M | 33.30% |
| Dec 30, 2011 | 640.20M | -47.19% |
| Dec 31, 2010 | 1.21B | 39.56% |
| Dec 31, 2009 | 868.60M | 68.99% |
| Dec 31, 2008 | 514.00M | -16.91% |
| Dec 31, 2007 | 618.60M | -54.96% |
| Dec 29, 2006 | 1.37B | -4.78% |
| Dec 30, 2005 | 1.44B | -15.13% |
| Dec 31, 2004 | 1.70B | 122.51% |
| Dec 31, 2003 | 763.80M | 70.57% |
| Dec 31, 2002 | 447.80M | -56.04% |
| Dec 31, 2001 | 1.02B | -55.42% |
| Dec 29, 2000 | 2.28B | 215.10% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zentalis Pharmaceuticals | 262.75M |
| Inovio Pharmaceuticals | 260.92M |
| Monte Rosa Therapeutics | 260.50M |
| Sanara MedTech | 260.05M |
| MultiPlan | 257.95M |
| CorMedix | 255.56M |
| AirSculpt Technologies | 255.03M |
| Nanobiotix | 254.40M |